4.8 Article

Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver

Journal

CELL METABOLISM
Volume 5, Issue 4, Pages 313-320

Publisher

CELL PRESS
DOI: 10.1016/j.cmet.2007.03.004

Keywords

-

Funding

  1. NCRR NIH HHS [P41 RR002584, RR-02584, P41 RR002584-190051] Funding Source: Medline
  2. NHLBI NIH HHS [R37 HL034557, HL-34557, R01 HL034557-19, R01 HL034557] Funding Source: Medline
  3. NIDDK NIH HHS [DK59632, U24 DK059632-04, U24 DK059632] Funding Source: Medline

Ask authors/readers for more resources

When dietary carbohydrate is unavailable, glucose required to support metabolism in vital tissues is generated via gluconeogenesis in the liver. Expression of phosphoenolpyruvate carboxykinase (PEPCK), commonly considered the control point for liver gluconeogenesis, is normally regulated by circulating hormones to match systemic glucose demand. However, this regulation fails in diabetes. Because other molecular and metabolic factors can also influence gluconeogenesis, the explicit role of PEPCK protein content in the control of gluconeogenesis was unclear. In this study, metabolic control of liver gluconeogenesis was quantified in groups of mice with varying PEPCK protein content. Surprisingly, livers with a 90% reduction in PEPCK content showed only a similar to 40% reduction in gluconeogenic flux, indicating a lower than expected capacity for PEPCK protein content to control gluconeogenesis. However, PEPCK flux correlated tightly with TCA cycle activity, suggesting that under some conditions in mice, PEPCK expression must coordinate with hepatic energy metabolism to control gluconeogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available